Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Countering hepatitis B virus infection using RNAi: how far are we from the clinic?

13 Sept 2011

Abstract excerpt

Globally, persistent HBV infection is a significant cause of public health problems. Currently available HBV therapies have variable efficacy and there is a need to develop improved treatment to prevent cirrhosis and hepatocellular carcinoma. Although RNA interference (RNAi)-based approaches have shown promise, accomplishing safe and sustained silencing by RNAi activators, as well as their efficient delivery to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to RNA Interference and Gene Delivery
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21913277
DOI: 10.1002/rmv.705

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Countering hepatitis B virus infection using RNAi: how far are we from the clinic?PMID 21913277Read ↗

Advances with RNAi-Based Therapy for Hepatitis B Virus InfectionSemantic proximity Read ↗

Opportunities for treating chronic hepatitis B and C virus infection using RNA interferenceSemantic proximity Read ↗

RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future ProspectsSemantic proximity Read ↗

Evaluation of Interfering RNA Efficacy in Treating Hepatitis B: Is It Promising?Semantic proximity Read ↗

Investigational RNA Interference Agents for Hepatitis BSemantic proximity Read ↗

Progress and Prospects of Anti-HBV Gene Therapy DevelopmentSemantic proximity Read ↗

Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNASemantic proximity Read ↗

Gene-Editing and RNA Interference in Treating Hepatitis B: A ReviewSemantic proximity Read ↗

Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intentSemantic proximity Read ↗

Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?Semantic proximity Read ↗

Short interfering RNA‐directed inhibition of hepatitis B virus replicationSemantic proximity Read ↗

Inhibition of hepatitis B virus expression and replication by RNA interference.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.